Julie Marie Vose, MD

  • 42153 Citations
  • 92 h-Index
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Julie Marie Vose is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.



Cerny, R., Issenberg, P., Bresnick, E., Kuszynski, C. A., Christman, J., Lynch, J. C., Tempero, M., Nagel, D., Smith, D. L., Kuszynski, C. A., Pour, P., Vose, J. M., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Sherman, S., Lawson, T. A., Johnson, D. R., Kessinger, M. A., Cowan, K. H., Hollingsworth, T., Rogan, E. G., Bridge, J. A., Volsky, D., Conrad, R., Nagel, D., Rhode, S., Ruddon, R., Ramspott, E., Pour, P., Gmeiner, W., Lewis, R. E., Borgstahl, G. E., Caplan, S. H., Band, H., Ganti, A. K. P., Meza, J. L., Black, J. D., Guda, B., Wang, J., Semerad, C. L. & Wang, G.

National Institutes of Health


Project: Research project

  • FLT-PET/CT for Therapy Monitoring of DLBCL

    Fayad, L., Quon, A. & Vose, J. M.

    National Institutes of Health


    Project: Research project

  • Research Output

    COVID-19 pandemic and its effects on cancer care, both good and bad

    Vose, J. M., Jun 2020, In : ONCOLOGY (United States). 3407, p. 244 1 p.

    Research output: Contribution to journalEditorial

    Open Access
  • Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost?

    Vose, J. M., Sep 15 2020, In : Oncology (Williston Park, N.Y.). 34, 9, p. 343 1 p.

    Research output: Contribution to journalEditorial

    Open Access
  • Fighting 2 enemies: Cancer and COVID-19

    Vose, J. M., May 2020, In : ONCOLOGY (United States). 3405, p. 155 1 p.

    Research output: Contribution to journalLetter

    Open Access

    Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button

    Holstein, S. A. & Vose, J. M., Sep 1 2020, In : Clinical Pharmacology and Therapeutics. 108, 3, p. 422-424 3 p.

    Research output: Contribution to journalComment/debate

    Open Access
    2 Scopus citations

    Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

    Torka, P., Kothari, S. K., Sundaram, S., Li, S., Medeiros, L. J., Ayers, E. C., Landsburg, D. J., Bond, D. A., Maddocks, K. J., Giri, A., Hess, B., Pham, L. Q., Advani, R., Liu, Y., Barta, S. K., Vose, J. M., Churnetski, M. C., Cohen, J. B., Burkart, M., Karmali, R. & 12 others, Zurko, J., Mehta, A., Olszewski, A. J., Lee, S., Hill, B. T., Burns, T. F., Lansigan, F., Rabinovich, E., Peace, D., Groman, A., Attwood, K. & Hernandez-Ilizaliturri, F. J., Jan 28 2020, In : Blood Advances. 4, 2, p. 253-262 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 2 Scopus citations